Atorvastatin calcium and Alginate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atorvastatin calcium (atorvastatin calcium) and Alginate (algin). Common drug interactions include nasopharyngitis among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Atorvastatin calcium and Alginate. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,310 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

What is Alginate?

Alginate has active ingredients of algin. eHealthMe is studying from 1,556 Alginate users. Check the latest studies of Alginate.



On Aug, 05, 2026

15 people who take Atorvastatin calcium and Alginate together, and have interactions are studied.

Atorvastatin calcium and Alginate drug interactions.

What are the common drug interactions of Atorvastatin Calcium and Alginate, by gender? *:

female:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Constipation
  4. Cough
  5. Diarrhoea
  6. Disease progression
  7. Drug ineffective
  8. Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
  9. Gastritis (inflammation of stomach)
  10. Headache (pain in head)

male:

  1. Cellulitis (infection under the skin)
  2. Muscle haemorrhage (bleeding in muscle)
  3. Deficiency anaemia
  4. Dyspepsia (indigestion)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Gynaecomastia (enlargement of the gland tissue of the male breast)
  7. Hypokalaemia (low potassium)
  8. Hypoxia (low oxygen in tissues)
  9. Melaena (the passage of black, tarry stools)
  10. Muscle spasms (muscle contraction)

What are the common drug interactions of Atorvastatin Calcium and Alginate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Diarrhoea
  3. Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
  4. Gastritis (inflammation of stomach)
  5. Iron deficiency anaemia
  6. Kidney infection
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Neuropsychiatric lupus (the various psychiatric and neurologic symptoms due to a multi system inflammatory disorder)
  10. Pain in extremity

50-59:

n/a

60+:

  1. Cellulitis (infection under the skin)
  2. Muscle haemorrhage (bleeding in muscle)
  3. Cough
  4. Decreased activity
  5. Deficiency anaemia
  6. Disease progression
  7. Dyspepsia (indigestion)
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Gynaecomastia (enlargement of the gland tissue of the male breast)
  10. Headache (pain in head)

What are the existing conditions these people have? *

  1. Stable Angina (a constant chest pain): 2 people, 13.33%
  2. Pain: 2 people, 13.33%
  3. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 13.33%
  4. Gout (uric acid crystals building up in the body): 2 people, 13.33%
  5. Asthma: 2 people, 13.33%
  6. Adverse Event: 2 people, 13.33%
  7. Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 1 person, 6.67%
  8. Nausea And Vomiting: 1 person, 6.67%
  9. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 1 person, 6.67%
  10. Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Atorvastatin calcium and Alginate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atorvastatin calcium and Alginate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alginate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atorvastatin calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alginate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium and algin (the active ingredients of Atorvastatin calcium and Alginate, respectively), and Atorvastatin calcium and Alginate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: